AvKARE 2024-04-24 Health critical FDA
Health · FDA · Recall #FDA-D-0444-2024
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx… Recall
Issued April 24, 2024 · AvKARE
In April 2024, AvKARE recalled the Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
What you should do
- 1 Stop using Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact AvKARE to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- AvKARE
- Category
- Health
- Recall date
- April 24, 2024
- Units affected
- Not reported
- Sold at
- US Nationwide.
- Recall number
- FDA-D-0444-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- AvKARE has 10 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.